2RU-19293-13504 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-29
Registered in v-safe
2021-01-29
Dose 1 — Moderna
2021-01-30
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities

Adult check-in
2021-01-30
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-02-01
Survey response — days 1–6 daily, dose 1
MedDRA: Injection site pain, Sleep disorder — Feeling: Good · Site: Pain

Free text: Moderate to severe pain at site that lasted a little longer than 48 hours. Waking me up frequently at night for two nights

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-29	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-01-30	priority 2/3

Free text

Release 3 — days 1–6 daily, dose 1

2021-02-01

Systemic reaction (other): Moderate to severe pain at site that lasted a little longer than 48 hours. Waking me up frequently at night for two nights

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Injection site pain	✓	✓	✓
SRO	Sleep disorder	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release